“oral”的搜索结果，显示 131-140 项，共有 4900 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

3. 牙脓肿- 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生. James M. Van Ess, M.D., D.D.S.. Oral ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

8. 扁桃体切除术- 医生与科室- 妙佑医疗国际

   ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) on Day 1 of each 28-day cycle (Cycle 1: 375 mg/m2; Cycles 2-6 ...

10. 花生过敏- 症状与病因- 妙佑医疗国际

    Oral Immunotherapy. NIH: National Institute of Allergy and Infectious Diseases. https://www.nih.gov/news-events/news-releases/oral-immunotherapy-induces ...